This service supports EIC Pathfinder and EIC Transition beneficiaries from the biotech, pharma, and healthtech sectors related to innovations to fight antimicrobial resistance (AMR) with R&D and business development advice and coaching sessions. This service aims to accelerate the efficiency of technology maturation, increase visibility/exposure, and help companies reach an investible stage. Advice will be delivered in all feasible ways, e.g. via e-mail exchange, via 1-1 calls, or in personal meetings. INCATE experts will analyse the strengths and weaknesses of the individual concept or technology and make the teams aware of potential translational hurdles which are foreseeable. This includes the development of competitive Target Product Profiles and related development paths, IP conflicts, regulatory issues, technical challenges, or conceptual constraints. EIC beneficiaries will also have the opportunity to get feedback from Pharma companies and industry experts. The duration of the service can vary and depends on the beneficiary’s needs. The service is implemented in a hybrid mode (mainly online).
Free of charge.
This service is restricted to innovative concepts in the field of antimicrobial resistance (AMR) and to TRL 1-4.
Are you in doubt if this is the right service for you, or do you want to get more information about the service? Get in touch with the EIC Partner providing this service through this query form!
Is this the service you are looking for? If so, you can apply to the service through EIC ACCESS+! Eligible applicants can also get co-funding through the EIC ACCESS+ initiative. Find out more on the project webiste.
Receive up to €60,000 in grants, covering up to 50% of the costs, to access specialised services from the EIC Service Catalogue. Learn more on the EIC ACCESS+ website.